Normalization of elevated liver enzymes due to V-1 Immunitor therapy
V-1 Immunitor (V1) is an oral AIDS vaccine currently being used as a therapeutic modality by HIV-positive patients. Upon interim analysis of phase I safety trial it has been discovered that patients who had elevated liver enzymes aspartate (AST/SGOT) and alanine (ALT/SGPT) aminotransferases have exp...
Guardado en:
Autores principales: | Jirathitikal,Vichai, Metadilogkul,Orapun, Bourinbaiar,Aldar S. |
---|---|
Lenguaje: | English |
Publicado: |
Pontificia Universidad Católica de Valparaíso
2003
|
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582003000100010 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recent developments in biotech industry outside of the USA and Western Europe: Report from BIO 2005
por: Bourinbaiar,Aldar S.
Publicado: (2006) -
Long-term mortality due to infection associated with elevated liver enzymes: a population-based cohort study
por: Tak Kyu Oh, et al.
Publicado: (2021) -
Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy.
por: Morven Cunningham, et al.
Publicado: (2021) -
Cascade enzymes within self-assembled hybrid nanogel mimicked neutrophil lysosomes for singlet oxygen elevated cancer therapy
por: Qing Wu, et al.
Publicado: (2019) -
Defining normal liver stiffness range in a normal healthy Chinese population without liver disease.
por: James Fung, et al.
Publicado: (2013)